Crystalloids/Colloids: Controversies

  • C. Sorbara
  • D. Pittarello
  • M. Primadei
Conference paper


Since 1918, intravenous fluid infusion in the treatment of shock has been fundamental to the resuscitation of critically ill patients [1]. Restoration of volume deficit is essential to survival of patients with hypovolemia; however, despite the importance of fluid therapy, controversy still exists over the choice of crystalloids or colloids as the ideal resuscitation fluid.


Plasma Volume Intravascular Volume Hydroxyethyl Starch Volume Replacement Colloid Osmotic Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cannon WB, Fraser J, Cowell EM (1918) The preventative treatment of wound shock. JAMA 70: 618–621Google Scholar
  2. 2.
    Haljamäe H (1998) Albumin: to use or not to use? Contemporary alternatives? In: Baron J-F, Treib J (eds) Volume replacement. Springer-Verlag, Berlin Heidelberg New York, pp 1–22CrossRefGoogle Scholar
  3. 3.
    Margarson MP, Soni N (1998) Serum albumin: touchstone or totem? Anaesthesia 53: 789–803PubMedCrossRefGoogle Scholar
  4. 4.
    Webb AR, Barclay SA, Bennett ED (1989) In vitro colloid osmotic pressure of commonly used plasma expanders and substitutes: a study of the diffusibility of colloid molecules. Intensive Care Med 15: 116–120PubMedCrossRefGoogle Scholar
  5. 5.
    Starling EH (1986) On the absorption of fluids from the connective tissues spaces. J Physiol 19: 312–326Google Scholar
  6. 6.
    Taylor AE (1981) Capillary fluid filtration: Starling forces and lymph flow. Circ Res 49: 557–575PubMedCrossRefGoogle Scholar
  7. 7.
    Arfors KE, Buckley PB (1980) Role of artificial colloids in rational fluid therapy. In: Tuma RF, White JV, Messmer K (eds) The role of hemodilution in optimal patient care. Zuckschwerdt Verlag, Munich, pp 100–123Google Scholar
  8. 8.
    Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471–1477PubMedCrossRefGoogle Scholar
  9. 9.
    Baron JF (2000) Crystalloids versus colloids in the treatment of hypovolemic shock. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 443–466Google Scholar
  10. 10.
    Kreimeier U, Peter K (1998) Strategies of volume therapy in sepsis and systemic inflammatory response syndrome. Kidney Int 53[Suppl 64]: S75–S79Google Scholar
  11. 11.
    Hinshaw LB (1996) Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 24: 1072–1078PubMedCrossRefGoogle Scholar
  12. 12.
    Boldt J 2000 Human albumin on the intensive care unit can we live without it. In Vincent J-L ed Yearbook of intensive care and emergency medicine. Springer Berlin Heidelberg New York pp 467–475Google Scholar
  13. 13.
    Hauser CJ, Shoemaker WC, et al (1980) Oxygen transport responses to colloid and crystalloid in critically ill surgical patients. Surg Gynecol Obstet 150: 811–816PubMedGoogle Scholar
  14. 14.
    Rackow EC, Mecher C, Astiz ME, et al (1989) Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med 17: 394–398PubMedCrossRefGoogle Scholar
  15. 15.
    Lazrove S, Waxman K, Shippy CR, et al (1980) Hemodynamic, blood volume and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patients. Crit Care Med 8: 302–306PubMedCrossRefGoogle Scholar
  16. 16.
    Sibbald WJ (1985) Myocardial function in a critically ill: factors influencing left and right ventricular performance in patient with sepsis and trauma. Surg Clin North Am 65: 867–893PubMedGoogle Scholar
  17. 17.
    Voerman HJ, Groenveld AB (1989) Blood viscosity and circulatory shock. Intensive Care Med 15: 72–78PubMedCrossRefGoogle Scholar
  18. 18.
    Foglia RP, Partington MT, Buckbeg GD et al (1986) Iatrogenic myocardial edema with crystalloid primes. Effect on left ventricular compliance, performance and perfusion. Curr Stud Hematol Blood Transfus 53: 53–63PubMedGoogle Scholar
  19. 19.
    Dart RC, Sanders AB (1998) Oxygen free radicals and myocardial reperfusion injury. Ann Emerg Med 17: 53–58CrossRefGoogle Scholar
  20. 20.
    Edwards JD, Nightingale P, Wilkins RG, et al (1989) Hemodynamic and oxygen transport response to modified fluid gelatin in critically ill patients. Crit Care Med 17: 996–998PubMedCrossRefGoogle Scholar
  21. 21.
    Shoemaker WC, Appel PL, Kram HB (1991) Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: dobutamine and dopamine effects. Crit Care Med 19: 672–688PubMedCrossRefGoogle Scholar
  22. 22.
    Matsuda H, Shoemaker WC (1975) Survivors’ and nonsurvivors’ responses to dextran 40. Hemodynamic and oxygen transport changes in critically ill patients. Arch Surg 110: 301–305PubMedCrossRefGoogle Scholar
  23. 23.
    Wang P, Hauptman JG, Chaudry IH (1990) Hemorrhage produces depression in microvascular blood flow which persists despite fluid resuscitation. Circ Shock 32: 307–318PubMedGoogle Scholar
  24. 24.
    Antonsson JB Boyle CC Kruithoff KL et al 1990 Validity of tometric measures of gut intramural pH during endotoxemia and mesenteric occlusion in pigs. Am J Physiol 259 G519–G523.Google Scholar
  25. 25.
    Mythen MG, Webb AR (1994) Intraoperative gut mucosal hypoperfusion is associated with increased post-operative complications and cost. Intensive Care Med 20: 99–104PubMedCrossRefGoogle Scholar
  26. 26.
    Marik PE, Iglesias J, Maini B (1997) Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneu-rysm repair. J Crit Care 12: 51–55PubMedCrossRefGoogle Scholar
  27. 27.
    Boldt J, Muller M, Heesen M, et al (1996) Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 24: 385–391PubMedCrossRefGoogle Scholar
  28. 28.
    Lowell JA, Schifferdecker C, Driscoll DF, et al (1990) Postoperative fluid overload: not a benign problem. Crit Care Med 18: 728–733PubMedCrossRefGoogle Scholar
  29. 29.
    Holcroft JW, Trunkey DD (1975) Pulmonary extravasation of albumin during and after hemor-rhagic shock in baboons. J Surg Res 18: 728–733CrossRefGoogle Scholar
  30. 30.
    Kreimeier U, Bruckner UB, Niemczyck S, et al (1990) Hyperosmotic saline dextran for resuscitation from hemorrhagic-traumatic hypotension: effect on regional blood flow. Circ Shock 32: 83–99PubMedGoogle Scholar
  31. 31.
    Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systemic review of randomized controlled trials. BMJ 317: 235–239CrossRefGoogle Scholar
  32. 32.
    Schierhout G, Roberts I (1998) Fluid resuscitation with colloids or crystalloids in critically ill patients: a systematic review of randomized trials. BMJ 316: 961–964PubMedCrossRefGoogle Scholar
  33. 33.
    Kreimeier U, Ruiz-Morales M, Messmer K (1993) Comparison of the effects of volume resuscitation with dextran 60 vs. Ringer’s lactate on central hemodynamics, regional blood flow, pulmonary function, and blood composition during hyperdynamic endotoxemia. Circ Shock 39: 89–99PubMedGoogle Scholar
  34. 34.
    Funk W, Baldinger V (1995) Microcirculatory perfusion during volume therapy. A comparative study using crystalloid or colloid in awake animals. Anesthesiology 82: 975–982PubMedCrossRefGoogle Scholar
  35. 35.
    Gallagher JD, Moore RA, Kerns D, et al (1985) Effects of colloid or crystalloid administration on pulmonary extravascular lung water in the postoperative period after coronary artery bypass grafting. Anesth Analg 64: 753–758PubMedGoogle Scholar
  36. 36.
    Gallagher TJ, Banner MJ, Barnes P (1985) Large volume crystalloid resuscitation does not increase extravascular lung water. Anesth Analg 64: 323–326PubMedGoogle Scholar
  37. 37.
    Moss GS, Lowe RJ, Jilek J, et al (1981) Colloid or crystalloid in the resuscitation of hemorrhagic shock: A controlled clinical trial. Surgery 89: 434–438PubMedGoogle Scholar
  38. 38.
    Mazzoni MC, Borgstrom P, Arfors KE, et al (1988) Dynamic fluid redistribution in hyperosmotic resuscitation of hypovolemic hemorrhage. Am J Physiol 255: H629–H637PubMedGoogle Scholar
  39. 39.
    Lopes OU, Pontieri V, Rochae Silva M Jr, et al (1981) Hyperosmotic NaCl and severe hemorrhagic shock: role of the innervated lung. Am J Physiol 241: H883–H890PubMedGoogle Scholar
  40. 40.
    Kien ND, Retain JA, White DA, et al (1991) Cardiac contractility and blood flow distribution following resuscitation with 7.5% hypertonic saline in anesthetized dogs. Circ Shock 35: 109–116PubMedGoogle Scholar
  41. 41.
    Prough DS, Whitley JM, Taylor CL, et al (1991) Regional cerebral blood flow following resuscitation from hemorrhagic shock with hypertonic saline. Influence of a subdural mass. Anesthesiology 75: 319–327PubMedCrossRefGoogle Scholar
  42. 42.
    Rachow EC, Falk JL, Fein A, et al (1983) Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 11: 839–850CrossRefGoogle Scholar
  43. 43.
    Fleck A, Raines G, Hawker F, et al (1985) Increased intravascular permeability: a major cause of hypoalbuminemia in disease and injury. Lancet: 781–784Google Scholar
  44. 44.
    Mishler JM (1984) Synthetic plasma volume expanders their pharmacology, safety, and clinical efficacy. Clin Hematol 13: 75–92Google Scholar
  45. 45.
    Nearman HS, Herman ML (1981) Toxic effects of colloids in the intensive care units. Crit Care Clin 7: 713–723Google Scholar
  46. 46.
    Lamke LO, Liljedahl SO (1976) Plasma volume expansion after infusion of 5%, 20% and 25% albumin solutions in patients. Resuscitation 5: 85–92PubMedCrossRefGoogle Scholar
  47. 47.
    Laxenaire MC, Charpentier C, Feldman L and the French Plasmasubstitutes Tolerance Study Group (1994) Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. Ann Fr Anaesth Reanim 13: 301CrossRefGoogle Scholar
  48. 48.
    Kovalik SG, Ledgerwood AM, Lucas CE, et al (1974) The cardiac effect of altered calcium homeostasis after albumin resuscitation. J Trauma 21: 275–279CrossRefGoogle Scholar
  49. 49.
    Ledgerwood AM, Lucas CE (1974) Postresuscitation hypertension, etiology, morbidity and treatment. Arch Surg 108: 531–538PubMedCrossRefGoogle Scholar
  50. 50.
    Salmon JB, Mythen MG (1993) Pharmacology and physiology of colloids. Blood Rev 7: 114–120PubMedCrossRefGoogle Scholar
  51. 51.
    Bergqvist D (1982) Dextran and haemostasis: a review. Acta Chir Scand 148: 633–640PubMedGoogle Scholar
  52. 52.
    Laubenthal H, Messmer K (1992) Allergic reactions to dextrans. In: Baron JF (ed) Plasma volume expansion. Arnette Blackwell, Paris.Google Scholar
  53. 53.
    Strauss RG, Stump DC, Henriksen RA, et al (1985) Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 25: 230–234PubMedCrossRefGoogle Scholar
  54. 54.
    Mishler JM, Hester JP, Heustis DW, et al (1983) Dosage and scheduling regimens for erythrocytesedimenting macromolecules. J Clin Apheresis 1: 130–143PubMedCrossRefGoogle Scholar
  55. 55.
    London MJ, HO JS, Triedman JK, et al (1989) A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 97: 785–797PubMedGoogle Scholar
  56. 56.
    Yeh T, Parmar JM, Rebeyka IM et al (1992) Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch. J Thorac Cardiovasc Surg 104: 659–665PubMedGoogle Scholar
  57. 57.
    Saddler JM, Horsey PJ (1987) The new generation gelatins. Anaesthesia 42: 998–1004PubMedCrossRefGoogle Scholar
  58. 58.
    Lundsgaart-Hansen P, Tschirren B (1980) Clinical experience with 120,000 units of modified fluid gelatin. Dev Biol Stand 48: 251–256Google Scholar
  59. 59.
    Choi PT, Yip G, Quinonez LG, et al (1999) Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27: 200–210PubMedCrossRefGoogle Scholar
  60. 60.
    Bunn F, Alderson P, Hawkins V (2001) Colloid solutions for fluid resuscitation (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software, pp 1–18Google Scholar
  61. 61.
    Boldt J, Lenz M, Kumle B, et al (1998) Volume replacement strategies on intensive care units: results from a postal survey. Intensive Care Med 24: 147–151PubMedCrossRefGoogle Scholar
  62. 62.
    Berger A (1998) Why albumin may not work BMJ 317: 240PubMedCrossRefGoogle Scholar
  63. 63.
    Offringa M (1998) Excess mortality after human albumin administration in critically ill patients. BMJ 317: 223–224PubMedCrossRefGoogle Scholar
  64. 64.
    Dung NM, Day NPJ, Tarn DTH, et al (1999) Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 29: 787–794PubMedCrossRefGoogle Scholar
  65. 65.
    Van der Sande FM Kooman JP Barendregt JNM et al 1999 Effect of intraveus saline albumin or hydroxyethyl starch on blood ume during combined ultrafiltration and hemodialysis. J Am Soc Nephrol 10 1303–1308Google Scholar
  66. 66.
    Ioannidis PA, Cappeleri JC, Lau J (1998) Issues in comparisons between meta-analyses and large trials. JAMA 279: 1089–1093PubMedCrossRefGoogle Scholar
  67. 67.
    Consensus Conference (1985) Fresh-frozen plasma: indications and risks. JAMA 253: 551–553CrossRefGoogle Scholar
  68. 68.
    Consensus Conference (1987) Platelet transfusion therapy. JAMA 257: 1777–1780CrossRefGoogle Scholar
  69. 69.
    Consensus Conference (1988) Perioperative red cell transfusion. JAMA 260: 2700–2703CrossRefGoogle Scholar
  70. 70.
    Vermeulen L, Ratko TA, Erstad BL, et al (1995) A paradigm for consensus. The university hospital consortium guidelines for the use of albumin, nonprotein colloid and crystalloid solutions. Arch Intern Med 155: 373–379PubMedCrossRefGoogle Scholar
  71. 71.
    Mangues I, Lloberas N, Ferrer MI, et al (1995) Criterios de utilizacion de albumina. Farm Clin 12: 271–277Google Scholar
  72. 72.
    Gines P, Arroyo V, Quintero E, et al (1987) Comparison of paracentesis and diuretics in the treatment of cirrhotic with tense ascitis. Gastroenterology 93: 234–241PubMedGoogle Scholar
  73. 73.
    Planas R, Gines P, Arroyo V, et al (1990) Dextran 70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Gastrenterology 99: 1736–1744Google Scholar
  74. 74.
    Subcommittee of the Victorian Drug Usage Advisory Committee (1992) Human albumin solutions: consensus statements for use in selected clinical situations. Med J Aust 157: 340–343Google Scholar
  75. 75.
    Durand-Zalesky I, Bonnet F, Rochant H, et al (1992) Usefulness of consensus conferences: the case of albumin. Lancet 340: 1388–1390CrossRefGoogle Scholar
  76. 76.
    Haljamäe H, Dahlqvist M, Walentin F (1997) Artificial colloids in clinical practice: pros and cons. Baillieres Clin Anaesthesiol 11: 49–79CrossRefGoogle Scholar
  77. 77.
    Mythen MG, Salmon JB, Webb AR (1993) The rational administration of colloids. Blood Rev 7: 223–228PubMedCrossRefGoogle Scholar
  78. 78.
    Haljamäe H (1999) Use of fluids in trauma. Int J Intensive Care 6: 20–30Google Scholar

Copyright information

© Springer-Verlag Italia 2002

Authors and Affiliations

  • C. Sorbara
    • 1
  • D. Pittarello
    • 1
  • M. Primadei
    • 1
  1. 1.Department of Pharmacology and AnaesthesiologyPadua General HospitalPaduaItaly

Personalised recommendations